West Pharmaceutical Services Thereafter increased by 92.7% to $52.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 95.5%, from $26.90M to $52.60M.
other_lessee_operating_lease_liability_to_be_paid_after__f4d16f| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $37.10M | $36.20M | $43.80M | $46.30M | $45.00M | $51.50M | $51.50M | $50.60M | $42.10M | $41.70M | $36.20M | $37.20M | $26.90M | $27.40M | $27.30M | $52.60M |
| QoQ Change | — | -2.4% | +21.0% | +5.7% | -2.8% | +14.4% | +0.0% | -1.7% | -16.8% | -1.0% | -13.2% | +2.8% | -27.7% | +1.9% | -0.4% | +92.7% |
| YoY Change | — | — | — | +24.8% | +24.3% | +17.6% | +11.2% | +12.4% | — | -19.0% | -29.7% | -26.5% | -35.5% | -24.3% | -26.6% | +95.5% |